![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Poland, P Teitelbaum and E Glover
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.
The admininistration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to C57BL/6J mice produces a dose-related increase in the hepatic uptake of [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin ([125I]Cl3DpD) in vivo and the binding of the radioligand to liver homogenate in vitro [Mol. Pharmacol. 36: 121-127 (1989)]. The TCDD-induced hepatic binding species was found to be predominantly in the microsomal fraction and was inactivated by heating at 60 degree, trypsin, and mercurials. The TCDD-induced binding species was found to have an apparent equilibrium dissociation constant, KD, ([125I]Cl3DpD) of 56 +/- 16 nM and a pool size, Bmax, of 22 +/- 5 nmol/g of liver. A number of halogenated dibenzo-p-dioxins, biphenyls, and polycyclic aromatic hydrocarbons compete with [125I]Cl3DpD binding to this species; all are aromatic and planar. The distinctive profile of this binding species, a protein of large pool size induced in the microsomal fraction of liver but not other tissues and induced by agonists for the Ah receptor, suggested that this moiety might be cytochrome P3-450. The coincidence of the major microsomal species covalently labeled with the photoaffinity ligand [125I]2-iodo-3-azido-7,8-dibromodibenzo-p-dioxin and that immunochemically stained with polyclonal antiserum that binds to cytochrome P3-450 confirms this hypothesis. This is a novel role for a cytochrome P-450 isozyme, as an induced sequestration site that enhances the hepatic localization of the agonist drug.
This article has been cited by other articles:
|
|
 |
|
  D. R. Bell, S. Clode, M. Q. Fan, A. Fernandes, P. M. D. Foster, T. Jiang, G. Loizou, A. MacNicoll, B. G. Miller, M. Rose, et al. Relationships between Tissue Levels of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), mRNAs, and Toxicity in the Developing Male Wistar(Han) Rat Toxicol. Sci., October 1, 2007; 99(2): 591 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dragin, T. P. Dalton, M. L. Miller, H. G. Shertzer, and D. W. Nebert For Dioxin-induced Birth Defects, Mouse or Human CYP1A2 in Maternal Liver Protects whereas Mouse CYP1A1 and CYP1B1 Are Inconsequential J. Biol. Chem., July 7, 2006; 281(27): 18591 - 18600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Curran, K. A. Miller, T. P. Dalton, C. V. Vorhees, M. L. Miller, H. G. Shertzer, and D. W. Nebert Genetic Differences in Lethality of Newborn Mice Treated In Utero with Coplanar versus Non-Coplanar Hexabromobiphenyl Toxicol. Sci., February 1, 2006; 89(2): 454 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Heiden, R. J. Hutz, and M. J. Carvan III Accumulation, Tissue Distribution, and Maternal Transfer of Dietary 2,3,7,8,-Tetrachlorodibenzo-p-Dioxin: Impacts on Reproductive Success of Zebrafish Toxicol. Sci., October 1, 2005; 87(2): 497 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Thomae, E. Glover, and C. A. Bradfield A Maternal Ahr Null Genotype Sensitizes Embryos to Chemical Teratogenesis J. Biol. Chem., July 16, 2004; 279(29): 30189 - 30194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Emond, L. S. Birnbaum, and M. J. DeVito Physiologically Based Pharmacokinetic Model for Developmental Exposures to TCDD in the Rat Toxicol. Sci., July 1, 2004; 80(1): 115 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Diliberto, M. J. DeVito, D. G. Ross, and L. S. Birnbaum Subchronic Exposure of [3H]-2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in Female B6C3F1 Mice: Relationship of Steady-State Levels to Disposition and Metabolism Toxicol. Sci., June 1, 2001; 61(2): 241 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, M. J. Santostefano, M. J. DeVito, and L. S. Birnbaum Extrapolation of a PBPK Model for Dioxins across Dosage Regimen, Gender, Strain, and Species Toxicol. Sci., July 1, 2000; 56(1): 49 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Schlezinger and J. J. Stegeman Dose and Inducer-Dependent Induction of Cytochrome P450 1A in Endothelia of the Eel, including in the Swimbladder Rete Mirabile, a Model Microvascular Structure Drug Metab. Dispos., June 1, 2000; 28(6): 701 - 708. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Doi, Z. Lou, E. Holmes, C.-L. J. Li, C. S. Venugopal, M. O. James, and K. M. Kleinow Effect of Micelle Fatty Acid Composition and 3,4,3',4'-Tetrachlorobiphenyl (TCB) Exposure on Intestinal [14C]-TCB Bioavailability and Biotransformation in Channel Catfish in Situ Preparations Toxicol. Sci., May 1, 2000; 55(1): 85 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Evans and M. E. Andersen Sensitivity Analysis of a Physiological Model for 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD): Assessing the Impact of Specific Model Parameters on Sequestration in Liver and Fat in the Rat Toxicol. Sci., March 1, 2000; 54(1): 71 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. LaPres, E. Glover, E. E. Dunham, M. K. Bunger, and C. A. Bradfield ARA9 Modifies Agonist Signaling through an Increase in Cytosolic Aryl Hydrocarbon Receptor J. Biol. Chem., February 25, 2000; 275(9): 6153 - 6159. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
